187 related articles for article (PubMed ID: 32857885)
1. Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.
Lina I; Tsai HW; Ding D; Davis R; Motz KM; Hillel AT
Laryngoscope; 2021 Jul; 131(7):1570-1577. PubMed ID: 32857885
[TBL] [Abstract][Full Text] [Related]
2. Identifying Phenotypically Distinct Fibroblast Subsets in Type 2 Diabetes-Associated Iatrogenic Laryngotracheal Stenosis.
Lina IA; Berges A; Ospino R; Davis RJ; Motz KM; Tsai HW; Collins S; Hillel AT
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):712-719. PubMed ID: 34126803
[TBL] [Abstract][Full Text] [Related]
3. Targeting metabolic abnormalities to reverse fibrosis in iatrogenic laryngotracheal stenosis.
Murphy MK; Motz KM; Ding D; Yin L; Duvvuri M; Feeley M; Hillel AT
Laryngoscope; 2018 Feb; 128(2):E59-E67. PubMed ID: 28940431
[TBL] [Abstract][Full Text] [Related]
4. M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts.
Motz K; Lina I; Murphy MK; Drake V; Davis R; Tsai HW; Feeley M; Yin LX; Ding D; Hillel A
Laryngoscope; 2021 Feb; 131(2):E346-E353. PubMed ID: 33051870
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts in Hypoxic Conditions Mimic Laryngotracheal Stenosis.
Yin LX; Motz KM; Samad I; Duvvuri M; Murphy M; Ding D; Hillel AT
Otolaryngol Head Neck Surg; 2017 May; 156(5):886-892. PubMed ID: 28349784
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glutaminase to reverse fibrosis in iatrogenic laryngotracheal stenosis.
Tsai HW; Motz KM; Ding D; Lina I; Murphy MK; Benner D; Feeley M; Hooper J; Hillel AT
Laryngoscope; 2020 Dec; 130(12):E773-E781. PubMed ID: 31904876
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.
Davis RJ; Lina I; Ding D; Engle EL; Taube J; Gelbard A; Hillel AT
Laryngoscope; 2021 May; 131(5):967-974. PubMed ID: 32557663
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Epithelial Changes in Laryngotracheal Stenosis.
Lina IA; Tsai HW; Berges AJ; Ospino RA; Davis RJ; Motz KM; Collins S; Ghosh B; Sidhaye V; Gelbard A; Hillel AT
Laryngoscope; 2022 Nov; 132(11):2194-2201. PubMed ID: 35141889
[TBL] [Abstract][Full Text] [Related]
9. Metabolic variations in normal and fibrotic human laryngotracheal-derived fibroblasts: A Warburg-like effect.
Ma G; Samad I; Motz K; Yin LX; Duvvuri MV; Ding D; Namba DR; Elisseeff JH; Horton MR; Hillel AT
Laryngoscope; 2017 Mar; 127(3):E107-E113. PubMed ID: 27585358
[TBL] [Abstract][Full Text] [Related]
10. Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis.
Tsai HW; Lina I; Motz KM; Chung L; Ding D; Murphy MK; Feeley M; Elisseeff JH; Hillel AT
Laryngoscope; 2021 Jul; 131(7):E2125-E2130. PubMed ID: 33433011
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of fibrosis in iatrogenic laryngotracheal stenosis: New discoveries and novel targets.
Xu M; Hu B; Chen J; Wang J; Li X
Biomed Pharmacother; 2024 Jan; 170():115995. PubMed ID: 38118348
[TBL] [Abstract][Full Text] [Related]
12. Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis.
Hillel AT; Tang SS; Carlos C; Skarlupka JH; Gowda M; Yin LX; Motz K; Currie CR; Suen G; Thibeault SL
mSphere; 2019 May; 4(3):. PubMed ID: 31043518
[TBL] [Abstract][Full Text] [Related]
13. T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.
Hillel AT; Ding D; Samad I; Murphy MK; Motz K
Laryngoscope; 2019 Jan; 129(1):177-186. PubMed ID: 30421427
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Assessment of the Immune Microenvironment in Patients With Iatrogenic Laryngotracheal Stenosis.
Davis RJ; Lina I; Green B; Engle EL; Motz K; Ding D; Taube JM; Gelbard A; Hillel AT
Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1257-1264. PubMed ID: 33290179
[TBL] [Abstract][Full Text] [Related]
15. Laryngotracheal stenosis: Mechanistic review.
Carpenter DJ; Hamdi OA; Finberg AM; Daniero JJ
Head Neck; 2022 Aug; 44(8):1948-1960. PubMed ID: 35488503
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Inflammatory Markers in Laryngotracheal Stenosis.
Motz KM; Yin LX; Samad I; Ding D; Murphy MK; Duvvuri M; Hillel AT
Otolaryngol Head Neck Surg; 2017 Sep; 157(3):466-472. PubMed ID: 28485188
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals.
Morrison RJ; Katsantonis NG; Motz KM; Hillel AT; Garrett CG; Netterville JL; Wootten CT; Majka SM; Blackwell TS; Drake WP; Gelbard A
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):107-115. PubMed ID: 30322354
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts.
Motz K; Samad I; Yin LX; Murphy MK; Duvvuri M; Ding D; Hillel AT
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1134-1140. PubMed ID: 28715559
[TBL] [Abstract][Full Text] [Related]
19. The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis.
Gelbard A; Wanjalla C; Wootten CT; Drake WP; Lowery AS; Wheeler DA; Cardenas MF; Sikora AG; Pathak RR; McDonnell W; Mallal S; Pilkinton M
Laryngoscope; 2021 Mar; 131(3):610-617. PubMed ID: 32603507
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-associated idiopathic laryngotracheal stenosis: presentation, management and results of surgical treatment.
Tapias LF; Rogan TJ; Wright CD; Mathisen DJ
Eur J Cardiothorac Surg; 2021 Jan; 59(1):122-129. PubMed ID: 33038218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
